ZAMBELLI ALBERTO

Licata, L., De Sanctis, R., Vingiani, A., Cosentini, D., Iorfida, M., Caremoli, E., et al. (2024). Real-world use of multigene signatures in early breast cancer: differences to clinical trials. BREAST CANCER RESEARCH AND TREATMENT, 205(1), 39-48 [10.1007/s10549-023-07227-0]. Detail

Bucci, C., Marmo, C., Soncini, M., Riccioni, M., Laursen, S., Gralnek, I., et al. (2024). The interaction of patients’ physical status and time to endoscopy on mortality risk in patients with upper gastrointestinal bleeding: A national prospective cohort study. DIGESTIVE AND LIVER DISEASE, 56(6), 1095-1100 [10.1016/j.dld.2023.11.024]. Detail

Antonini, S., Pedersini, R., Birtolo, M., Baruch, N., Carrone, F., Jaafar, S., et al. (2024). Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 47(2), 433-442 [10.1007/s40618-023-02174-5]. Detail

Gerosa, R., De Sanctis, R., Jacobs, F., Benvenuti, C., Gaudio, M., Saltalamacchia, G., et al. (2024). Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: clinical trials, current impact, and future directions. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 196(April 2024) [10.1016/j.critrevonc.2024.104324]. Detail

Conforti, F., Pala, L., De Pas, T., Zattarin, E., Catania, C., Cocorocchio, E., et al. (2024). Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: An Expert Consensus on Open Issues for Future Research. CLINICAL CANCER RESEARCH, 30(6), 1093-1103 [10.1158/1078-0432.ccr-23-1836]. Detail